ERS Genomics Jun 28 New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurge by ERS Genomics | June 28, 2022 4390 Dublin, Ireland | ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Cytosurge AG (‘Cytosurge‘). This is a non-exclusive licensing agreement granting Cytosurge access to ... Read more > Press Release Corporate FluidFM Applications Jun 28, 2022 Press Release
Claudia Frey Jun 27 The start-ups taking nanoneedles into the clinic by Claudia Frey | June 27, 2022 2579 Nature Nanotechnology | Nanoneedle start-ups are traversing the biotech valley of death — from fundamental university research into commercial development in advanced therapeutics and diagnostics. How... Read more > Press Clipping Corporate Jun 27, 2022 Press Clipping
Stony Brook University (SUNY) Jun 22 Research Centered on Single Cells May Open Doors to New Discoveries on Disease Processes by Stony Brook University (SUNY) | June 22, 2022 2374 Stony Brook, NY | Gábor Balázsi , PhD, and his research team in the Laufer Center and the Department of Biomedical Engineering at Stony Brook University are embarking upon a new way to research cells,... Read more > Press Release Corporate FluidFM Applications Jun 22, 2022 Press Release
Claudia Frey Mar 30 Cytosurge launches cell line engineering services based on proprietary FluidFM® technology by Claudia Frey | March 30, 2022 4108 Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for gene... Read more > Press Release Corporate FluidFM Applications Mar 30, 2022 Press Release
Claudia Frey Mar 07 Multiplexing Speeds up Writing and Editing DNA by Claudia Frey | March 7, 2022 1737 Labiotech.eu | While scientists can read DNA fast, editing and writing it is not that easy. Increasing the speed of editing and writing DNA sequences will be critical to ushering in new applications o... Read more > Press Clipping Mar 7, 2022 Press Clipping
Claudia Frey Jan 18 R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisse by Claudia Frey | January 18, 2022 3891 Zurich | Cytosurge , a leading global provider for precision single cell manipulation, is delighted to announce that together with the Laboratory of Biosensors and Bioelectronics (LBB) at the Swiss Fe... Read more > Press Release Corporate FluidFM Applications Jan 18, 2022 Press Release
Katarina Svitek Jan 03 Mitochondria transplantation with FluidFM by Katarina Svitek | January 3, 2022 4563 Today, we are happy to introduce you to Christoph Gäbelein who developed a FluidFM-based approach to extract, inject and transplant organelles from and into living cells with subcellular spatial resol... Read more > Company Blog FluidFM Applications Jan 3, 2022 Company Blog
Claudia Frey Dec 22 Season's Greetings & Highlights in 2021 by Claudia Frey | December 22, 2021 3824 The past year has been a year of successful transformation and growth for us, even in these difficult times. Without your support and the great work of our employees, this would not have been possible... Read more > Company Blog Company Life Corporate Dec 22, 2021 Company Blog
Claudia Frey Aug 04 Partnership between Central Scientific Commerce and Cytosurge by Claudia Frey | August 4, 2021 4222 Zurich | We are delighted to announce our collaboration with CSC, a well-established and renowned Japanese organization specialized in the distribution of systems for life science research. Within thi... Read more > Press Release Corporate Aug 4, 2021 Press Release
Claudia Frey Mar 24 Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks by Claudia Frey | March 24, 2021 4094 Zurich | Cytosurge , a leading global provider for precision single cell manipulation , announced today that its pioneering, patented FluidFM nano-probe enabled CRISPR multiplexing to generate monoclo... Read more > Press Release Corporate FluidFM Applications Mar 24, 2021 Press Release
Paul Monnier Mar 08 FluidFM: A new approach to CRISPR gene editing by Paul Monnier | March 8, 2021 4905 With traditional delivery methods, such as lipofection or electroporation, the success of CRISPR-Cas mediated gene editing is often subpar due to poor cell viability and low transfection efficiency ra... Read more > Company Blog FluidFM Applications Mar 8, 2021 Company Blog
Claudia Frey Oct 01 Novel Approaches to Overcome CRISPR In Vitro Delivery Challenges by Claudia Frey | October 1, 2020 3108 EBR October 2020 | In order for CRISPR gene editing to reach its full potential, we must develop in vitro delivery approaches that will allow us to work with hard-to-transfect cells, large repair temp... Read more > Press Clipping FluidFM Applications Oct 1, 2020 Press Clipping
